Tracheobronchial involvement in Wegener's granulomatosis

T. E. Daum, Ulrich Specks, T. V. Colby, Eric Edell, M. W. Brutinel, U. B S Prakash, R. A. DeRemee

Research output: Contribution to journalArticle

165 Citations (Scopus)

Abstract

This study was designed to characterize the clinical spectrum and course of tracheobronchial involvement in Wegener's granulomatosis (WG). Of the 51 patients with biopsy-proven WG who underwent bronchoscopy at least once at our institution between January 1982 and November 1993, 30 (59%) had endobronchial abnormalities due to WG. Initial findings included subglottic stenosis in five (17%), ulcerating tracheobronchitis with or without inflammatory pseudotumors in 18 (60%), tracheal or bronchial stenosis without inflammation in four (13%), and hemorrhage without identifiable source in two (4%) patients. Nine patients with ulcerating tracheobronchitis on initial study had subsequent bronchoscopies for continued symptoms, which in seven cases documented the progression from ulcerating tracheobronchitis to stenosis without inflammation. Bronchoscopic interventions included dilation by rigid bronchoscope in three, YAG-laser treatment in one, and placement of silastic airway stents in three patients. Only the stents provided persistent airway patency. Endobronchial biopsies were performed on 21 occasions in 17 patients. Half of the specimens were helpful in establishing the diagnosis and in all but three in assessing disease activity. While antineutrophil cytoplasmic antibody liters reflect overall disease activity, no correlation with endobronchial inflammatory activity was apparent.

Original languageEnglish (US)
Pages (from-to)522-526
Number of pages5
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume151
Issue number2 I
StatePublished - 1995

Fingerprint

Granulomatosis with Polyangiitis
Pathologic Constriction
Bronchoscopy
Stents
Plasma Cell Granuloma
Inflammation
Biopsy
Bronchoscopes
Antineutrophil Cytoplasmic Antibodies
Solid-State Lasers
Dilatation
Hemorrhage

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Daum, T. E., Specks, U., Colby, T. V., Edell, E., Brutinel, M. W., Prakash, U. B. S., & DeRemee, R. A. (1995). Tracheobronchial involvement in Wegener's granulomatosis. American Journal of Respiratory and Critical Care Medicine, 151(2 I), 522-526.

Tracheobronchial involvement in Wegener's granulomatosis. / Daum, T. E.; Specks, Ulrich; Colby, T. V.; Edell, Eric; Brutinel, M. W.; Prakash, U. B S; DeRemee, R. A.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 151, No. 2 I, 1995, p. 522-526.

Research output: Contribution to journalArticle

Daum, TE, Specks, U, Colby, TV, Edell, E, Brutinel, MW, Prakash, UBS & DeRemee, RA 1995, 'Tracheobronchial involvement in Wegener's granulomatosis', American Journal of Respiratory and Critical Care Medicine, vol. 151, no. 2 I, pp. 522-526.
Daum, T. E. ; Specks, Ulrich ; Colby, T. V. ; Edell, Eric ; Brutinel, M. W. ; Prakash, U. B S ; DeRemee, R. A. / Tracheobronchial involvement in Wegener's granulomatosis. In: American Journal of Respiratory and Critical Care Medicine. 1995 ; Vol. 151, No. 2 I. pp. 522-526.
@article{70278a7295b642ea8c47c0c6a4c0bdab,
title = "Tracheobronchial involvement in Wegener's granulomatosis",
abstract = "This study was designed to characterize the clinical spectrum and course of tracheobronchial involvement in Wegener's granulomatosis (WG). Of the 51 patients with biopsy-proven WG who underwent bronchoscopy at least once at our institution between January 1982 and November 1993, 30 (59{\%}) had endobronchial abnormalities due to WG. Initial findings included subglottic stenosis in five (17{\%}), ulcerating tracheobronchitis with or without inflammatory pseudotumors in 18 (60{\%}), tracheal or bronchial stenosis without inflammation in four (13{\%}), and hemorrhage without identifiable source in two (4{\%}) patients. Nine patients with ulcerating tracheobronchitis on initial study had subsequent bronchoscopies for continued symptoms, which in seven cases documented the progression from ulcerating tracheobronchitis to stenosis without inflammation. Bronchoscopic interventions included dilation by rigid bronchoscope in three, YAG-laser treatment in one, and placement of silastic airway stents in three patients. Only the stents provided persistent airway patency. Endobronchial biopsies were performed on 21 occasions in 17 patients. Half of the specimens were helpful in establishing the diagnosis and in all but three in assessing disease activity. While antineutrophil cytoplasmic antibody liters reflect overall disease activity, no correlation with endobronchial inflammatory activity was apparent.",
author = "Daum, {T. E.} and Ulrich Specks and Colby, {T. V.} and Eric Edell and Brutinel, {M. W.} and Prakash, {U. B S} and DeRemee, {R. A.}",
year = "1995",
language = "English (US)",
volume = "151",
pages = "522--526",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2 I",

}

TY - JOUR

T1 - Tracheobronchial involvement in Wegener's granulomatosis

AU - Daum, T. E.

AU - Specks, Ulrich

AU - Colby, T. V.

AU - Edell, Eric

AU - Brutinel, M. W.

AU - Prakash, U. B S

AU - DeRemee, R. A.

PY - 1995

Y1 - 1995

N2 - This study was designed to characterize the clinical spectrum and course of tracheobronchial involvement in Wegener's granulomatosis (WG). Of the 51 patients with biopsy-proven WG who underwent bronchoscopy at least once at our institution between January 1982 and November 1993, 30 (59%) had endobronchial abnormalities due to WG. Initial findings included subglottic stenosis in five (17%), ulcerating tracheobronchitis with or without inflammatory pseudotumors in 18 (60%), tracheal or bronchial stenosis without inflammation in four (13%), and hemorrhage without identifiable source in two (4%) patients. Nine patients with ulcerating tracheobronchitis on initial study had subsequent bronchoscopies for continued symptoms, which in seven cases documented the progression from ulcerating tracheobronchitis to stenosis without inflammation. Bronchoscopic interventions included dilation by rigid bronchoscope in three, YAG-laser treatment in one, and placement of silastic airway stents in three patients. Only the stents provided persistent airway patency. Endobronchial biopsies were performed on 21 occasions in 17 patients. Half of the specimens were helpful in establishing the diagnosis and in all but three in assessing disease activity. While antineutrophil cytoplasmic antibody liters reflect overall disease activity, no correlation with endobronchial inflammatory activity was apparent.

AB - This study was designed to characterize the clinical spectrum and course of tracheobronchial involvement in Wegener's granulomatosis (WG). Of the 51 patients with biopsy-proven WG who underwent bronchoscopy at least once at our institution between January 1982 and November 1993, 30 (59%) had endobronchial abnormalities due to WG. Initial findings included subglottic stenosis in five (17%), ulcerating tracheobronchitis with or without inflammatory pseudotumors in 18 (60%), tracheal or bronchial stenosis without inflammation in four (13%), and hemorrhage without identifiable source in two (4%) patients. Nine patients with ulcerating tracheobronchitis on initial study had subsequent bronchoscopies for continued symptoms, which in seven cases documented the progression from ulcerating tracheobronchitis to stenosis without inflammation. Bronchoscopic interventions included dilation by rigid bronchoscope in three, YAG-laser treatment in one, and placement of silastic airway stents in three patients. Only the stents provided persistent airway patency. Endobronchial biopsies were performed on 21 occasions in 17 patients. Half of the specimens were helpful in establishing the diagnosis and in all but three in assessing disease activity. While antineutrophil cytoplasmic antibody liters reflect overall disease activity, no correlation with endobronchial inflammatory activity was apparent.

UR - http://www.scopus.com/inward/record.url?scp=0028852840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028852840&partnerID=8YFLogxK

M3 - Article

C2 - 7842215

AN - SCOPUS:0028852840

VL - 151

SP - 522

EP - 526

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2 I

ER -